<DOC>
	<DOC>NCT00724633</DOC>
	<brief_summary>Patients currently receiving hemodialysis will be randomized to receive 1 of 3 dialysate sodium prescriptions. The effects on blood pressure, interdialytic weight gain, thirst, and intradialytic symptoms will be assessed.</brief_summary>
	<brief_title>Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>patients on 3 times weekly hemodialysis of at least 3 months elevated average ambulatory blood pressures current dialysate sodium prescription 140mEq/L average predialysis serum sodium &lt;140mEq/L frequent intradialytic hypotension estimated life expectancy &lt;1 year nonadherence to dialysis prescription pregnancy inability or unwillingness to complete study measures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>dialysate</keyword>
	<keyword>sodium</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>blood pressure</keyword>
	<keyword>thirst</keyword>
	<keyword>intradialytic symptoms</keyword>
	<keyword>interdialytic weight gain</keyword>
	<keyword>extracellular fluid balance</keyword>
	<keyword>mechanisms</keyword>
</DOC>